|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.9250 USD | +13.29% |
|
+31.64% | -31.48% |
| 11-05 | Ocugen, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Ocugen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUGEN, INC. | Other Biotechnology & Medical Research | +13.29% | +31.64% | -31.48% | -32.97% | -90.97% | 314M |  |  | |
- Stock Market
- Stocks
- OCGN Stock
- Charts Ocugen, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
